SLC52A3 and riboflavin transporter deficiency: Recently, several clinical reports have mentioned that SLC52A3 mutations have been detected in patients with a neurological disorder (Brown-Vialetto-Van Laere syndrome; BVVLS), wherein fatty acid metabolism is impaired14, 15, 16, 17, 18, 19, 20, 21.